Endocrinology
Trilostane for Dogs With Hyperadrenocorticism
The primary goals of trilostane therapy are resolving clinical signs of hyperadrenocorticism and avoiding oversuppression of the adrenal axis.
Menu
The primary goals of trilostane therapy are resolving clinical signs of hyperadrenocorticism and avoiding oversuppression of the adrenal axis.
This rare case of adrenal-dependent AHAC provides evidence that trilostane therapy may effectively manage associated clinical signs and improve quality of life if surgical intervention is not pursued.
DOCP is a safe and effective mineralocorticoid replacement therapy when used in dogs with primary hypoadrenocorticism.
Four-year-old Siberian husky Olaf was diagnosed with diabetes.
Stay current with the latest techniques and information – sign up below to start your FREE Today’s Veterinary Practice subscription today.
Start My Subscription